Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes

S. Kotani; F. Kinoshita; I. Morisaki; T. Shimono; T. Okunaga; H. Takada; M. Tsujimoto; Y. Watanabe; K. Kato; T. Shiba; S. Kusumoto; S. Okada

Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes

S. Kotani, F. Kinoshita, I. Morisaki, T. Shimono, T. Okunaga, H. Takada, M. Tsujimoto, Y. Watanabe, K. Kato, T. Shiba, S. Kusumoto, S. Okada

DEN - Dental Sciences

Research output: Contribution to journal › Article › peer-review

36 Citations (Scopus)

Abstract

Addition of a lauroyl, stearoyl or docosanoyl group to the primary hydroxy group at the C-6 position of N-acetylmuramyl-L-alanyl-D-isoglutamine gave lipophilic derivatives that had definite adjuvancies in induction of delayed-type hypersensitivity and enhancement of antibody production against a test protein antigen, ovalbumin, when administered to guinea pigs as liposomes, that is, without mineral oil. When administered as mineral oil-in-water emulsion, including Ribi-type emulsions, rather than as water-in-mineral oil emulsions, N-acetylmuramyl-L-alanyl-D-isoglutamine and its 6-O-acyl derivatives showed only weak immunoadjuvancies.

Original language	English
Pages (from-to)	95-103
Number of pages	9
Journal	Biken Journal, Journal of the Research Institute for Microbial Diseases
Volume	20
Issue number	3-4
Publication status	Published - 1977

ASJC Scopus subject areas

Immunology and Microbiology(all)
Medicine(all)
Infectious Diseases
Microbiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Kotani, S., Kinoshita, F., Morisaki, I., Shimono, T., Okunaga, T., Takada, H., Tsujimoto, M., Watanabe, Y., Kato, K., Shiba, T., Kusumoto, S., & Okada, S. (1977). Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes. Biken Journal, Journal of the Research Institute for Microbial Diseases, 20(3-4), 95-103.

Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes. / Kotani, S.; Kinoshita, F.; Morisaki, I. et al.

In: Biken Journal, Journal of the Research Institute for Microbial Diseases, Vol. 20, No. 3-4, 1977, p. 95-103.

Research output: Contribution to journal › Article › peer-review

Kotani, S, Kinoshita, F, Morisaki, I, Shimono, T, Okunaga, T, Takada, H, Tsujimoto, M, Watanabe, Y, Kato, K, Shiba, T, Kusumoto, S & Okada, S 1977, 'Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes', Biken Journal, Journal of the Research Institute for Microbial Diseases, vol. 20, no. 3-4, pp. 95-103.

@article{bea90067722a428ba4a1abb4af4be95b,

title = "Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes",

abstract = "Addition of a lauroyl, stearoyl or docosanoyl group to the primary hydroxy group at the C-6 position of N-acetylmuramyl-L-alanyl-D-isoglutamine gave lipophilic derivatives that had definite adjuvancies in induction of delayed-type hypersensitivity and enhancement of antibody production against a test protein antigen, ovalbumin, when administered to guinea pigs as liposomes, that is, without mineral oil. When administered as mineral oil-in-water emulsion, including Ribi-type emulsions, rather than as water-in-mineral oil emulsions, N-acetylmuramyl-L-alanyl-D-isoglutamine and its 6-O-acyl derivatives showed only weak immunoadjuvancies.",

author = "S. Kotani and F. Kinoshita and I. Morisaki and T. Shimono and T. Okunaga and H. Takada and M. Tsujimoto and Y. Watanabe and K. Kato and T. Shiba and S. Kusumoto and S. Okada",

year = "1977",

language = "English",

volume = "20",

pages = "95--103",

journal = "Biken Journal, Journal of the Research Institute for Microbial Diseases",

issn = "0006-2324",

number = "3-4",

}

TY - JOUR

T1 - Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes

AU - Kotani, S.

AU - Kinoshita, F.

AU - Morisaki, I.

AU - Shimono, T.

AU - Okunaga, T.

AU - Takada, H.

AU - Tsujimoto, M.

AU - Watanabe, Y.

AU - Kato, K.

AU - Shiba, T.

AU - Kusumoto, S.

AU - Okada, S.

PY - 1977

Y1 - 1977

N2 - Addition of a lauroyl, stearoyl or docosanoyl group to the primary hydroxy group at the C-6 position of N-acetylmuramyl-L-alanyl-D-isoglutamine gave lipophilic derivatives that had definite adjuvancies in induction of delayed-type hypersensitivity and enhancement of antibody production against a test protein antigen, ovalbumin, when administered to guinea pigs as liposomes, that is, without mineral oil. When administered as mineral oil-in-water emulsion, including Ribi-type emulsions, rather than as water-in-mineral oil emulsions, N-acetylmuramyl-L-alanyl-D-isoglutamine and its 6-O-acyl derivatives showed only weak immunoadjuvancies.

AB - Addition of a lauroyl, stearoyl or docosanoyl group to the primary hydroxy group at the C-6 position of N-acetylmuramyl-L-alanyl-D-isoglutamine gave lipophilic derivatives that had definite adjuvancies in induction of delayed-type hypersensitivity and enhancement of antibody production against a test protein antigen, ovalbumin, when administered to guinea pigs as liposomes, that is, without mineral oil. When administered as mineral oil-in-water emulsion, including Ribi-type emulsions, rather than as water-in-mineral oil emulsions, N-acetylmuramyl-L-alanyl-D-isoglutamine and its 6-O-acyl derivatives showed only weak immunoadjuvancies.

UR - http://www.scopus.com/inward/record.url?scp=0017573866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017573866&partnerID=8YFLogxK

M3 - Article

C2 - 614856

AN - SCOPUS:0017573866

VL - 20

SP - 95

EP - 103

JO - Biken Journal, Journal of the Research Institute for Microbial Diseases

JF - Biken Journal, Journal of the Research Institute for Microbial Diseases

SN - 0006-2324

IS - 3-4

ER -

Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L- alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this